ARCHIVES

Phase III Xilonix Study Halted Following Unscheduled Analysis

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

Duke Halts Third Trial; Coauthor Disputes Claim That Data Validation Was Blinded

October 23, 2009

HHS Approves Six State Plans To Insure Women With Cancer

June 8, 2001

Susan Horwitz Succeeds Waun Ki Hong As AACR President

April 12, 2002

GAO Offers Two Suggestions For Plant Screening

April 4, 1980

Program Project Scores Have Compressed Review Shuld Return To Rank Order; Broder

October 2, 1992

FDA says new tools needed to speed therapeutics development.

March 26, 2004